Apples and oranges: Comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation

Circulation

Volumn 118, Issue 24, 2008, Pages 2488-2490

  Callans, David J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Ablation; Antiarrhythmia agents; Atrial fibrillation; Editorials

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; WARFARIN;

ANTICOAGULATION; CATHETER ABLATION; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFICACY; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; THROMBOEMBOLISM; TREATMENT FAILURE; DISEASE FREE SURVIVAL; NOTE; RANDOMIZED CONTROLLED TRIAL;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; DISEASE-FREE SURVIVAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 58149384246     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.823179     Document Type: Editorial

References (14)

1. Natale A, Raviele A, Arentz T, Calkins H, Chen S, Haissaguerre M, Hindricks G, Ho Y, Kuck K, Marchlinski F, Napolitano C, Packer D, Pappone C, Prystowsky E, R. S., Shah D, Themistoclakis S, Verma A. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2007;18:560-580.
2. Calkins H, Brugada J, Packer D, Cappato R, Chen S, Crijns H, Damiano RJ, Davies D, Haines D, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck K, Lindsay B, Marchlinski F, McCarthy P, Mont J, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin J, Shemin R. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up: a report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007;8:816-861.
3. Jais P, Cauchemez B, Made L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clémenty J, Haïssaguerre M. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118: 2498-2505.
4. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000;342:913-920.
5. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293:2634-2640.
6. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale D. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, mulitcentre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27:216-221.
7. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol. 2006;48:2340-2347.
8. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, Jr., Bates ER, Lehmann MH, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V, Morady F. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354:934-941.
9. Hsu L, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie J, Scavee C, Bordachar P, Clementy J, Haïssaguerre M. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004;351:2373-2383.
10. Gentlesk P, Sauer W, Gerstenfeld E, Lin D, Dixit S, Zado E, Callans D, Marchlinski F. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:9-14.
11. Zado E, Callans D, Riley M, Hutchinson M, Garcia F, Bala R, Lin D, Cooper J, Verdino R, Russo A, Dixit S, Gerstenfeld E, Marchlinski F. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2008;19:621-626.
12. Cappato R, Calkins H, Chen S, Davies W, Iesaka Y, Kalman J, Kim Y, Klein G, Packer D, Skanes A. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100-1105.
13. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG; AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation. 2004;109: 1509-1513.
14. Beyerbach D, Zipes D. Mortality as an endpoint in atrial fibrillation. Heart Rhythm. 2004;1:(2 Suppl):B8-B18.